Clinical trial
68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial
NCT02358018 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Expanded access
- Overall status
- No longer available
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.